证券记录 · 已归档季度
SWTX
SpringWorks Therapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
+4Δ持有人
11.91M持有股份
$525.67M报告持仓市值
+4新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 +14.5% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2025 | 16 | -1 | 23.61M | $1.11B | +1 | −2 |
| Q1 2025 | 14 | +4 | 11.91M | $525.67M | +4 | — |
| Q4 2024 | 10 | -3 | 10.41M | $375.97M | — | −3 |
| Q3 2024 | 12 | 0 | 9.81M | $314.31M | — | — |
| Q2 2024 | 12 | — | 10.32M | $388.74M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 2.92M | -2.8% | $128.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.58M | -21.1% | $113.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.58M | -21.1% | $113.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.72M | +2.7% | $75.72M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.72M | +2.7% | $75.72M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.66M | +329.0% | $73.41M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 1.66M | +329.0% | $73.41M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 833.50K | +346.9% | $36.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Duquesne Family Office ✦ | 615.93K | -28.4% | $27.18M | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 503.87K | 新增 | $22.24M | 0.0% | New | 1 | SEC ↗ |
| 11 | Soros Fund Management ✦ | 456.83K | -23.9% | $20.16M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 251.51K | -32.6% | $11.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 185.90K | 新增 | $8.20M | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 50.94K | 新增 | $2.25M | 0.0% | New | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 50.94K | 新增 | $2.25M | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 50.94K | 新增 | $2.25M | 0.0% | New | 1 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 39.65K | 新增 | $1.75M | 0.0% | New | 1 | SEC ↗ |
| 23 | Wellington Management ✦ | 30.56K | -2.0% | $1.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Wellington Management ✦ | 30.56K | -2.0% | $1.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Wellington Management ✦ | 30.56K | -2.0% | $1.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Wellington Management ✦ | 30.56K | -2.0% | $1.35M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $22.24M | 0.0% |
| Renaissance Technologies | $8.20M | 0.0% |
| Marshall Wace | $2.25M | 0.0% |
| Marshall Wace | $2.25M | 0.0% |
| Marshall Wace | $2.25M | 0.0% |
| Point72 Asset Management | $1.75M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 1 股份, $47 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据